NPTX2 upregulation in Vasc~Sp9D8 and L5~Sp9D3 is counter to findings of NPTX2 downregulation in AD73, but this discrepancy could reflect evolving changes or compensation as a factor of risk, early pathology, and more advanced AD. Here, NPTX2 is linked to Alzheimer disease.